Jason Kantor, Ph.D., has served as Chief Business Officer of Nurix since October 2023, and served in various finance and business strategy roles since joining the company in July 2020. Prior to joining Nurix, Dr. Kantor served as a Senior Biopharma Analyst at Artisan Partners, where he covered industry trends for both large and small cap biotech and pharma companies globally. He also served as Board President at Biotech Partners, meeting the non-profit’s goals of increasing corporate sponsorship and gaining support from local government. Dr. Kantor previously served as Managing Director, Biotechnology Analyst at Credit Suisse, RBC Capital Markets and WR Hambrecht + Co, focusing on innovative biotech companies and building successful healthcare and research franchises. Prior to that, he held a position as Vice President, Biotechnology Analyst at JP Morgan Chase & Co. Dr. Kantor holds a B.A. in Biology from the University of California, San Diego and a Ph.D. in Cell and Development Biology from Harvard University.
'